Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 24 Oct 2017 Planned number of patients changed from 72 to 32.
- 10 Jun 2017 Biomarkers information updated
- 11 Apr 2016 Status changed from not yet recruiting to recruiting.